Niagen Bioscience, Inc. (NAGE)
5.02
+0.16
(+3.29%)
USD |
NASDAQ |
Feb 23, 16:00
5.15
+0.13
(+2.59%)
After-Hours: 04:14
Niagen Bioscience Shareholders Equity (Quarterly) : 70.68M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 631.90M |
| Nephros, Inc. | 10.01M |
| Harrow, Inc. | 47.02M |
| Astrana Health, Inc. | 775.54M |
| Clover Health Investments Corp. | 340.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.14M |
| Total Liabilities (Quarterly) | 27.46M |
| Debt to Equity Ratio | 0.0432 |
| Current Ratio | 4.122 |
| Net Debt Paydown Yield | 0.00% |